1. Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
   Subhayan Sur et al, 2021, Cancers CrossRef
2. Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3
   Xin Qi et al, 2020, Molecules CrossRef
3. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
   Mahdi Eskandarian Boroujeni et al, 2022, Frontiers in Immunology CrossRef
4. Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
   Martyna Plens-Galaska et al, 2018, Frontiers in Immunology CrossRef
5. Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
   Megha Budhwani et al, 2018, Frontiers in Oncology CrossRef
6. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
   Malgorzata Szelag et al, 2016, Oncotarget CrossRef